Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways.
暂无分享,去创建一个
[1] H. Erickson. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. , 1993, Current opinion in cell biology.
[2] J. Healey,et al. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. , 1993, Cancer research.
[3] R. Derynck,et al. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. , 1993, Science.
[4] D. Johnson,et al. Structural and functional diversity in the FGF receptor multigene family. , 1993, Advances in cancer research.
[5] R. Tucker,et al. Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF. , 1993, Journal of cell science.
[6] J. Forrester,et al. Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells. , 1992, The Journal of biological chemistry.
[7] S. Jhanwar,et al. Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype. , 1992, Oncogene.
[8] M. Herlyn,et al. Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. , 1992, Oncogene.
[9] Y. Nishizuka. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.
[10] V. Lightner,et al. Expression of human tenascin in synovitis and its regulation by interleukin-1. , 1992, Arthritis and rheumatism.
[11] S. Hoffman,et al. Species diversity of neuronectin and cytotactin expression patterns in the vertebrate central nervous system , 1992, Brain Research.
[12] E. Mackie,et al. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. , 1992, The American journal of pathology.
[13] David J. Anderson,et al. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130 , 1992, Cell.
[14] R. Kolesnick,et al. Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. , 1992, Science.
[15] A. Huvos,et al. Ewing's sarcoma: new approaches to histogenesis and molecular plasticity. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[16] D. Moscatelli,et al. The FGF family of growth factors and oncogenes. , 1992, Advances in cancer research.
[17] R. Halaban,et al. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. , 1992, Oncogene.
[18] L. Liotta,et al. Tumor invasion and metastasis: an imbalance of positive and negative regulation. , 1991, Cancer research.
[19] B. Aggarwal,et al. Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines. , 1991, Cancer research.
[20] M. Sporn,et al. Cytokines in context , 1991, The Journal of cell biology.
[21] J. Lanchbury,et al. Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. , 1991, Journal of immunology.
[22] S. Gil,et al. Nerve Growth Factor Mediates Monosialoganglioside‐Induced Release of Fibronectin and J1/Tenascin from C6 Glioma Cells , 1991, Journal of neurochemistry.
[23] G. Edelman,et al. Cell adhesion molecules: implications for a molecular histology. , 1991, Annual review of biochemistry.
[24] R. Ross,et al. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. , 1990, Cell.
[25] G. Edelman,et al. Identification and characterization of the promoter for the cytotactin gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[26] M. Thornhill,et al. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. , 1990, Journal of immunology.
[27] V. Rosen,et al. Growth factors influencing bone development , 1990, Journal of Cell Science.
[28] J. Massagué,et al. The transforming growth factor-beta family. , 1990, Annual review of cell biology.
[29] M. Melamed,et al. Immunohistochemical analysis of human neuronectin expression in normal, reactive, and neoplastic tissues. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[30] P. Garin‐Chesa,et al. Cell type-specific control of human neuronectin secretion by polypeptide mediators and phorbol ester. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[31] L. Greene,et al. Functional receptors for nerve growth factor on Ewing's sarcoma and Wilm's tumor cells , 1989, Journal of cellular physiology.
[32] D. Bigner,et al. Tenascin/hexabrachion in human skin: biochemical identification and localization by light and electron microscopy , 1989, The Journal of cell biology.
[33] D. Morton,et al. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. , 1989, Journal of immunology.
[34] T. Triche,et al. Stimulation of human neuronectin secretion by brain-derived growth factors , 1989, Brain Research.
[35] P. Ekblom,et al. Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions [published erratum appears in J Cell Biol 1989 Mar;108(3):following 1175] , 1988, The Journal of cell biology.
[36] W. Halfter,et al. Induction of tenascin in healing wounds , 1988, The Journal of cell biology.
[37] Shigeki,et al. Tenascin: cDNA cloning and induction by TGF‐beta. , 1988, The EMBO journal.
[38] A. Waage,et al. Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice , 1988, The Journal of experimental medicine.
[39] M. Melamed,et al. Definition of an extracellular matrix protein in rostral portions of the human central nervous system , 1988, Brain Research.
[40] I. Thesleff,et al. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro , 1987, The Journal of cell biology.
[41] R. Chiquet‐Ehrismann,et al. Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme , 1987, The Journal of cell biology.
[42] J. Silver,et al. Differential expression of the human Thy-1 gene in rodent-human somatic cell hybrids [corrected]. , 1987, Journal of immunology.
[43] J. Vilček,et al. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[44] R. Chiquet‐Ehrismann,et al. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis , 1986, Cell.
[45] G. Edelman,et al. Altered expression of neuronal cell adhesion molecules induced by nerve injury and repair , 1986, The Journal of cell biology.
[46] G. Edelman,et al. Site-restricted expression of cytotactin during development of the chicken embryo , 1986, The Journal of cell biology.
[47] H. Erickson,et al. A six-armed oligomer isolated from cell surface fibronectin preparations , 1984, Nature.
[48] D. Bigner,et al. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. , 1983, Cancer research.
[49] Ruddle Fh,et al. Somatic cell genetic analysis of human cell surface antigens. , 1982 .